0001443669-26-000010
SEC filingProto Labs, Inc. reported revenue of $533.1 million for fiscal year 2025, generating a gross profit of $237.1 million. The company achieved income from operations of $25.1 million and net income of $21.2 million, with comprehensive income totaling $28.2 million. Key profitability metrics include a gross margin of 44.5% and an operating margin of 4.7%. The company generated $74.5 million in net cash from operating activities, with free cash flow of $59.7 million after accounting for capital expenditures. The balance sheet shows total assets of $763.4 million, with shareholders' equity of $673.9 million and total liabilities of $89.5 million, indicating a strong equity position. The company repurchased $43.0 million of common stock during the year.
Proto Labs, Inc. reported total revenue of $533.1 million for fiscal year 2025, with cost of revenue totaling $296.0 million. The company generated gross profit of $237.1 million, representing a gross margin of 44.5%. Operating expenses totaled $212.0 million, consisting of marketing and sales ($98.3 million), research and development ($42.8 million), general and administrative ($69.8 million), restructuring and transformation costs ($749,000), and costs related to disposal and exit activities (-$342,000). This resulted in income from operations of $25.1 million, representing an operating margin of 4.7%. After other income of $6.0 million and income tax provision of $9.8 million, the company reported net income of $21.2 million. Comprehensive income was $28.2 million, including foreign currency translation adjustments of $6.8 million and net unrealized gains on investments in securities of $195,000.
The filing does not provide segment breakdown or geographic mix data for revenue. The total revenue figure of $533.1 million represents the company's consolidated performance across all operations. No specific growth drivers, customer concentration information, or product/service category breakdowns are disclosed in the provided data. The company's revenue generation appears to be consolidated without segment-level disclosure in the financial statements provided.
The company maintained a gross margin of 44.5% for fiscal year 2025, calculated from gross profit of $237.1 million on revenue of $533.1 million. Operating margin was 4.7%, derived from operating income of $25.1 million. The cost structure shows marketing and sales expenses representing 18.4% of revenue, research and development at 8.0% of revenue, and general and administrative expenses at 13.1% of revenue. Net income margin was 4.0%, calculated from net income of $21.2 million. The company reported basic and diluted earnings per share of $1.00, with 23.9 million basic shares and 24.2 million diluted shares outstanding.
The company generated $74.5 million in net cash from operating activities, starting with net income of $21.2 million and adding back non-cash items including depreciation and amortization ($33.8 million), stock-based compensation ($15.7 million), and deferred taxes ($2.9 million). Working capital changes contributed $27.8 million, primarily from decreases in accounts receivable ($12.5 million) and increases in accrued liabilities ($14.0 million). Investing activities used $13.4 million, mainly for purchases of property and equipment ($14.8 million) and marketable securities ($17.0 million), partially offset by proceeds from asset sales ($834,000) and maturities of marketable securities ($17.6 million). Free cash flow was $59.7 million (operating cash flow of $74.5 million minus capital expenditures of $14.8 million). The balance sheet shows total assets of $763.4 million, including cash and equivalents ($110.8 million), property and equipment net ($215.3 million), and goodwill ($274.0 million). Total liabilities were $89.5 million, with shareholders' equity of $673.9 million, resulting in a debt-to-equity ratio of 0.13.
The provided financial data does not include management guidance, strategic priorities, or specific risk factors from the filing. No forward-looking statements, growth projections, or strategic initiatives are disclosed in the financial statements provided. The company's financial performance for fiscal year 2025 is presented without commentary on future expectations or business outlook.